Our Publications

Publications

We are committed to rigorously evaluating the diagnostic performance of tests we offer. We believe that offering the highest quality of testing requires thoughtful examination of how a test performs in clinical practice, to ensure optimal test interpretation and accurate patient diagnosis. Publications relating to our expertise and work on diagnostic testing for neurologic diseases can be found below:

Testing for Antibodies in Autoimmune Encephalitis

Testing for neural antibodies in autoimmune encephalitis: who, what, where, when, why, and how

Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults

Optimizing the diagnostic performance of neural antibody testing for paraneoplastic and autoimmune encephalitis in clinical practice

Lack of Comprehensive Neural Antibody Testing: A Contributor to Diagnostic Delay in Autoimmune Encephalitis

Clinical Sensitivity, Specificity, and Predictive Value of Neural Antibody Testing for Autoimmune Encephalitis

Neural Antibody Testing for Autoimmune Encephalitis: A Canadian Single-Centre Experience

Neural Antibody Testing in Patients with Suspected Autoimmune Encephalitis

Diagnosing autoimmune limbic encephalitis

Testing for High-Risk Paraneoplastic Antibodies

The Positive Predictive Value of Onconeural Antibody Testing: A Retrospective Review

Testing for Antibodies in GAD65 Neurologic Autoimmunity

Positive Predictive Value of Anti-GAD65 ELISA Cut-Offs for Neurological Autoimmunity

Testing for Antibodies in NMOSD and MOGAD

Testing for myelin oligodendrocyte glycoprotein antibodies: Who, what, where, when, why, and how

Myelin oligodendrocyte glycoprotein antibody titers by fixed cell-based assay: positive predictive value and impact of sample collection timing

Testing for Antibodies Against Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in the Diagnosis of Patients With Suspected Autoimmune Myelopathy

Testing for Antibodies in Inflammatory Neuropathy

Evaluating yield and utilization of ganglioside antibody testing in clinical practice

Testing for Antibodies in Myasthenia Gravis

Improving sensitivity of autoantibody testing for myasthenia gravis using cell-based assays: an evaluation of strategies that may be used in clinical practice

Testing for Acetylcholine Receptor and Muscle-Specific Tyrosine Kinase Antibodies by Fixed Cell-Based Assay in Clinical Practice: Positive Predictive Value for Myasthenia Gravis

Comparison of fixed cell-based assay to radioimmunoprecipitation assay for acetylcholine receptor antibody detection in myasthenia gravis

Fixed cell-based assays for autoantibody detection in myasthenia gravis: a diagnostic breakthrough

Testing for Antibodies in Inflammatory Myopathy

Positive predictive value of myositis antibody line blot testing in patients with suspected idiopathic inflammatory myopathy

Testing for Alzheimer's Disease

Positive predictive value of CSF biomarker testing for a clinical diagnosis of Alzheimer's disease